Suchergebnisse - "Yllescas, María"

PubPharm (17)

1

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19 : the COVID-19 SEIMC score

enthalten in: Thorax | 2021

von Berenguer, J. | Borobia, A. | Ryan, P. | +109

2

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19 : a multicentre cohort study

enthalten in: The Lancet. Infectious diseases | 2021

von Gutiérrez-Gutiérrez, B. | Del Toro, M. | Borobia, A. | +110

CommentIn: Lancet Infect Dis. 2021 Jun;21(6):744-745. - PMID 33636149

3

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Perez Elias, M. | Alejos, B. | Gutierrez, M. | +56

4

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state : a multicentre cohort study (SAM-COVID-19)

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Rodríguez-Baño, J. | Pachón, J. | Carratalà, J. | +169

CommentIn: Clin Microbiol Infect. 2021 Feb;27(2):158-159. - PMID 33007475

5

Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide : GESIDA 9016

enthalten in: Open forum infectious diseases | 2020

von Perez Valero, I. | Cabello, A. | Ryan, P. | +11

6

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020

von Berenguer, J. | Ryan, P. | Rodríguez-Baño, J. | +136

CommentIn: J Infect. 2021 May;82(5):e6-e10. - PMID 33582205

7

Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2020

von Salgüero, S. | Rojo, D. | Berenguer, J. | +43

8

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Pérez Elías, M. | Alejos, B. | Vivancos, M. | +55

ErratumIn: J Antimicrob Chemother. 2019 Oct 1;74(10):3124. - PMID 31377772

9

Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients : 48-week results of the KIRAL study

enthalten in: PloS one | 2018

von Troya, J. | Montejano, R. | Ryan, P. | +16

10

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression : Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017

von Pulido, F. | Ribera, E. | Lagarde, M. | +118